醫療科技
NEW

AI數位醫療股將登興櫃！雲象科技遞交申請
新聞集錦
NEW

11/01《生醫焦點雷達》

生技醫藥
NEW

台新藥眼科新藥APP13007獨家授權葡萄牙DAVI拓銷歐洲市場

GBI International
GBIHighlights

Beyond mRNA Vaccines: What's the Next Frontier?

2023-12-01/GlobalBio & Investment
BeyondmRNAVaccines:What'stheNextFrontier? Everwonderedwhy Moderna isdivingintorarediseasetherapies?Findouttheintriguingstorybehindtheirboldmove!Plus,discoverhowmRNAtherapyisrevolutionizingthedevel...
GBI International
GBIHighlights

AusBiotech 2023: Over 22 Countries Delegates, 170 Speakers and 50 Sessions

2023-12-01/GlobalBio & Investment
AusBiotech2023:Over22CountriesDelegates,170Speakersand50SessionsAustralia’sbiggestweekinbiotech,AusBiotech2023nationalconferenceisheldinBrisbanefrom1-3November.AusBiotech2023launchedwithmorethan...
GBI International
GBIHighlights

BioJapan 2023: Taiwan at the Forefront of Regenerative Medicine

2023-12-01/GlobalBio & Investment
BioJapan2023:TaiwanattheForefrontofRegenerativeMedicine BioJapan2023,Japan'spremierthree-daybiotechnologyevent,kickedoffatthe PACIFICOYokohama ConventionCenteronOctober11th.AroundtwentyTaiwaneseco...
GBI International
GBIHighlights

Real-life “Hanten Jutsushiki”! CiRA Director, Jun Takahashi, Utilizes iPSCs for Brain Treatment

2023-12-01/GlobalBio & Investment
Real-life“HantenJutsushiki”!CiRADirector,JunTakahashi,UtilizesiPSCsforBrainTreatment JunTakahashi,thedirectorofKyotoUniversity'sCenterforiPSCellandApplication(CiRA)andaprominentfigurei...
GBI International
GBIHighlights

Taiwan's Cell Therapy: 20 Years of Progress - Reviewing Current Clinical Trials

2023-12-01/GlobalBio & Investment
Taiwan'sCellTherapy:20YearsofProgress-ReviewingCurrentClinicalTrials Themuch-debatedRegenerativeMedicineActhasbeenthesubjectofongoingdiscussionsformanyyears.Thoughithasconsolidatedfromthreedraftgu...
GBI International
GBIHighlights

The Winners of 2023 Best Bio CEO Award held by Globalbio have been revealed!

2023-12-01/GlobalBio & Investment
TheWinnersof2023BestBioCEOAwardheldbyGlobalbiohavebeenrevealed!Thisyearwehave CytoArm｜Armed-Tcelltherapy, LeadgeneBiomedical,Inc.,and SunWayBiotechCo.,LTD. winningtheawards.Thefirstwinner,CytoArm,feat...
GBI International
GBIHighlights

AI Revolutionizing Biomedicine: Recent Advances and Healthcare Applications

2023-12-01/GlobalBio & Investment
AIRevolutionizingBiomedicine:RecentAdvancesandHealthcareApplicationsAIanditsgenerativecapabilitieshavegainedsignificantattention,particularlyinthefieldofbiomedicine,sinceChatGPT'srisetoprominencei...
GBI International
GBIHighlights

Rebuilding Psychological Safety After Drug Allergy: A 4-Step Approach

2023-12-01/GlobalBio & Investment
RebuildingPsychologicalSafetyAfterDrugAllergy:A4-StepApproachAdrugallergyoccurswhentheimmunesystemreactstoanonprescription,prescription,orherbalmedicine.Patientssufferingfromdrugallergiesexperiencevar...
GBI International
GBIHighlights

LuminX Fluorescent Nano-Diamond Platform Achieves in Tracking Lung Injury, Head and Neck Cancer

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】LuminXFluorescentNano-DiamondPlatformAchievesinTrackingLungInjury,HeadandNeckCancer.TheinnovativetrackingplatformofLuminXcombinesnanoscal...
GBI International
GBIHighlights

EirGenix's Development Capacity Extends to CDMO and Biosimilars Across the US, Europe, and Taiwan

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】EirGenix'sDevelopmentCapacityExtendstoCDMOandBiosimilarsAcrosstheUS,Europe,andTaiwan. EirGenix(6589.TWO)isoneofthefewcompaniesinAsiat...
GBI International
GBIHighlights

Merck and Pythia Biotech Signed a MOU on Using Organ-on-Chip Technology to Develop...

2023-12-01/GlobalBio & Investment
MerckandPythiaBiotechSignedaMOUonUsingOrgan-on-ChipTechnologytoDevelopNext-GenerationPlatformforDrugTesting OnJune9, MerckKGaA,Darmstadt,Germany andTaiwanstartupPythiaBiotechsignedaMemorandumofUnderst...
GBI International
GBIHighlights

iXensor's CDMO New Business Model Accelerates Next-Generation At-Home Testing and...

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】iXensor'sCDMONewBusinessModelAcceleratesNext-GenerationAt-HomeTestingandPOCTProductDevelopment iXensor(6734.TWO),establishedin2012,istheworld'sfir...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務